ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers

Hongqi Peng, Fengji Xu, Rashmi Pershad, Kelly K. Hunt, Marsha L. Frazier, Andrew Berchuck, Joe Gray, David Hogg, Robert C. Bast, Yinhua Yu

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

In our previous work, we had characterized ARHI as an imprinted putative tumor-suppressor gene in ovarian and breast cancers. ARHI is expressed in primary breast and ovarian cell lines but largely absent from the corresponding malignant tumors. Moreover, the non-imprinted functional allele is typically deleted in malignant cells. Since ARHI bad been mapped to 1p31, a common deletion site in breast and ovarian cancer and male germ-cell tumors, in this study, we set out to define precisely the physical location of ARHI at 1p31 and to determine if this location lies within the smallest common region of deletion in breast and ovarian cancers. To this end, we first carried out radiation hybrid mapping of ARHI and surrounding markers, followed by a high-resolution study of loss of heterozygosity at 1p31 in 49 ovarian and breast cancers. Combining a radiation hybrid map and a physical map of the region encompassing ARHI, 3 discrete regions of minimal deletion were found at 1p31 in breast and ovarian cancers. ARHI is the most common deletion region at 1p31. Two other less common regions of deletion were found centromeric to this gene. One of them centered on D1S207 and the other one included and was proximal to D1S488. We also confirmed the preferential loss of non-imprinted functional allele in 7 of 9 tumor specimens. These data support the possibility that ARHI is a tumor-suppressor gene and suggest that additional tumor-suppressor genes may lie proximal to ARHI at 1p31. The data obtained from our study should aid in the identification and characterization of genes in this novel imprinted region. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)690-694
Number of pages5
JournalInternational Journal of Cancer
Volume86
Issue number5
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Chromosome Deletion
Ovarian Neoplasms
Breast Neoplasms
Tumor Suppressor Genes
Radiation Hybrid Mapping
Alleles
Loss of Heterozygosity
Genes
Neoplasms
Breast
Cell Line

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers. / Peng, Hongqi; Xu, Fengji; Pershad, Rashmi; Hunt, Kelly K.; Frazier, Marsha L.; Berchuck, Andrew; Gray, Joe; Hogg, David; Bast, Robert C.; Yu, Yinhua.

In: International Journal of Cancer, Vol. 86, No. 5, 2000, p. 690-694.

Research output: Contribution to journalArticle

Peng, Hongqi ; Xu, Fengji ; Pershad, Rashmi ; Hunt, Kelly K. ; Frazier, Marsha L. ; Berchuck, Andrew ; Gray, Joe ; Hogg, David ; Bast, Robert C. ; Yu, Yinhua. / ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers. In: International Journal of Cancer. 2000 ; Vol. 86, No. 5. pp. 690-694.
@article{6a695d1a5e3247bc9a57f03bd0547401,
title = "ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers",
abstract = "In our previous work, we had characterized ARHI as an imprinted putative tumor-suppressor gene in ovarian and breast cancers. ARHI is expressed in primary breast and ovarian cell lines but largely absent from the corresponding malignant tumors. Moreover, the non-imprinted functional allele is typically deleted in malignant cells. Since ARHI bad been mapped to 1p31, a common deletion site in breast and ovarian cancer and male germ-cell tumors, in this study, we set out to define precisely the physical location of ARHI at 1p31 and to determine if this location lies within the smallest common region of deletion in breast and ovarian cancers. To this end, we first carried out radiation hybrid mapping of ARHI and surrounding markers, followed by a high-resolution study of loss of heterozygosity at 1p31 in 49 ovarian and breast cancers. Combining a radiation hybrid map and a physical map of the region encompassing ARHI, 3 discrete regions of minimal deletion were found at 1p31 in breast and ovarian cancers. ARHI is the most common deletion region at 1p31. Two other less common regions of deletion were found centromeric to this gene. One of them centered on D1S207 and the other one included and was proximal to D1S488. We also confirmed the preferential loss of non-imprinted functional allele in 7 of 9 tumor specimens. These data support the possibility that ARHI is a tumor-suppressor gene and suggest that additional tumor-suppressor genes may lie proximal to ARHI at 1p31. The data obtained from our study should aid in the identification and characterization of genes in this novel imprinted region. (C) 2000 Wiley-Liss, Inc.",
author = "Hongqi Peng and Fengji Xu and Rashmi Pershad and Hunt, {Kelly K.} and Frazier, {Marsha L.} and Andrew Berchuck and Joe Gray and David Hogg and Bast, {Robert C.} and Yinhua Yu",
year = "2000",
doi = "10.1002/(SICI)1097-0215(20000601)86:5<690::AID-IJC14>3.0.CO;2-K",
language = "English (US)",
volume = "86",
pages = "690--694",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers

AU - Peng, Hongqi

AU - Xu, Fengji

AU - Pershad, Rashmi

AU - Hunt, Kelly K.

AU - Frazier, Marsha L.

AU - Berchuck, Andrew

AU - Gray, Joe

AU - Hogg, David

AU - Bast, Robert C.

AU - Yu, Yinhua

PY - 2000

Y1 - 2000

N2 - In our previous work, we had characterized ARHI as an imprinted putative tumor-suppressor gene in ovarian and breast cancers. ARHI is expressed in primary breast and ovarian cell lines but largely absent from the corresponding malignant tumors. Moreover, the non-imprinted functional allele is typically deleted in malignant cells. Since ARHI bad been mapped to 1p31, a common deletion site in breast and ovarian cancer and male germ-cell tumors, in this study, we set out to define precisely the physical location of ARHI at 1p31 and to determine if this location lies within the smallest common region of deletion in breast and ovarian cancers. To this end, we first carried out radiation hybrid mapping of ARHI and surrounding markers, followed by a high-resolution study of loss of heterozygosity at 1p31 in 49 ovarian and breast cancers. Combining a radiation hybrid map and a physical map of the region encompassing ARHI, 3 discrete regions of minimal deletion were found at 1p31 in breast and ovarian cancers. ARHI is the most common deletion region at 1p31. Two other less common regions of deletion were found centromeric to this gene. One of them centered on D1S207 and the other one included and was proximal to D1S488. We also confirmed the preferential loss of non-imprinted functional allele in 7 of 9 tumor specimens. These data support the possibility that ARHI is a tumor-suppressor gene and suggest that additional tumor-suppressor genes may lie proximal to ARHI at 1p31. The data obtained from our study should aid in the identification and characterization of genes in this novel imprinted region. (C) 2000 Wiley-Liss, Inc.

AB - In our previous work, we had characterized ARHI as an imprinted putative tumor-suppressor gene in ovarian and breast cancers. ARHI is expressed in primary breast and ovarian cell lines but largely absent from the corresponding malignant tumors. Moreover, the non-imprinted functional allele is typically deleted in malignant cells. Since ARHI bad been mapped to 1p31, a common deletion site in breast and ovarian cancer and male germ-cell tumors, in this study, we set out to define precisely the physical location of ARHI at 1p31 and to determine if this location lies within the smallest common region of deletion in breast and ovarian cancers. To this end, we first carried out radiation hybrid mapping of ARHI and surrounding markers, followed by a high-resolution study of loss of heterozygosity at 1p31 in 49 ovarian and breast cancers. Combining a radiation hybrid map and a physical map of the region encompassing ARHI, 3 discrete regions of minimal deletion were found at 1p31 in breast and ovarian cancers. ARHI is the most common deletion region at 1p31. Two other less common regions of deletion were found centromeric to this gene. One of them centered on D1S207 and the other one included and was proximal to D1S488. We also confirmed the preferential loss of non-imprinted functional allele in 7 of 9 tumor specimens. These data support the possibility that ARHI is a tumor-suppressor gene and suggest that additional tumor-suppressor genes may lie proximal to ARHI at 1p31. The data obtained from our study should aid in the identification and characterization of genes in this novel imprinted region. (C) 2000 Wiley-Liss, Inc.

UR - http://www.scopus.com/inward/record.url?scp=0034095516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034095516&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(20000601)86:5<690::AID-IJC14>3.0.CO;2-K

DO - 10.1002/(SICI)1097-0215(20000601)86:5<690::AID-IJC14>3.0.CO;2-K

M3 - Article

C2 - 10797292

AN - SCOPUS:0034095516

VL - 86

SP - 690

EP - 694

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 5

ER -